Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Geron (GERN) EBIT: 2010-2025

Historic EBIT for Geron (GERN) over the last 16 years, with Sep 2025 value amounting to -$13.9 million.

  • Geron's EBIT rose 50.78% to -$13.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$63.1 million, marking a year-over-year increase of 69.66%. This contributed to the annual value of -$173.7 million for FY2024, which is 10.42% up from last year.
  • As of Q3 2025, Geron's EBIT stood at -$13.9 million, which was down 11.51% from -$12.5 million recorded in Q2 2025.
  • Geron's EBIT's 5-year high stood at -$12.5 million during Q2 2025, with a 5-year trough of -$69.3 million in Q2 2024.
  • Its 3-year average for EBIT is -$37.3 million, with a median of -$40.1 million in 2023.
  • In the last 5 years, Geron's EBIT plummeted by 85.70% in 2023 and then surged by 82.04% in 2025.
  • Over the past 5 years, Geron's EBIT (Quarterly) stood at -$31.0 million in 2021, then crashed by 35.40% to -$42.0 million in 2022, then fell by 29.41% to -$54.3 million in 2023, then soared by 63.07% to -$20.1 million in 2024, then surged by 50.78% to -$13.9 million in 2025.
  • Its EBIT was -$13.9 million in Q3 2025, compared to -$12.5 million in Q2 2025 and -$16.7 million in Q1 2025.